Home Tags Drugs
Drugs Related Content
CBD is at the forefront of pharmacology. So why has the European Commission changed its recommended status to “Narcotic”? Read on to find out more.
Here, we learn all about the ‘opioid epidemic’ and how e-Learning for Healthcare’s e-PAIN programme is helping NHS staff to overcome it.
Here, we learn how Mile High Labs, a leading processor of hemp-derived cannabinoids, have raised Series B equity financing and are preparing for global CPG partnerships.
Kathleen Denoodt continues to enlighten us on the subject of medical cannabis, particularly imports to Germany and the Netherlands.
A new public health app by DRUID® measures factors to give an overall score of impairment, evolving the classic idea of drug testing.
A study in mice has shown long-lasting effects from juvenile social isolation and suggests methods of potential treatment.
Researchers at the College of Information Sciences and Technology at Penn State have developed an artificial intelligence (AI) algorithm to help identify homeless youth at risk of substance abuse.
New research shows that the gender gap in drug development trials results in an overmedication of women by healthcare professionals.
Paula Rhone-Adrien, leading Family law Barrister, explores the implicit bias of race and the British justice system.
A promising idea for lung cancer treatment has been developed by researchers at Lund University.
Researchers say that the use of drugs to create glowing bacteria could decrease the need for prescribing antibiotics.
Manager EU Research at Centexbel, Guy Buyle introduces REMADYL, a H2020 project focused on the removal of legacy substances from PVC via a continuous and sustainable extrusion process.
Dr Christian Löfke, responsible for research and product development at BioBloom, walks us through the rudiments of essential oils as a potential modulator of the endocannabinoid system.
Joseph Najjar and Andrew K. Udit, PhD from the Department of Chemistry at Occidental College enlighten us on the importance of Cytochromes P450 in medicine and industry.
Prof Dr Freimut Schliess, Director of Science & Innovation at the Profil Institut für Stoffwechselforschung GmbH, shares a vision for remote decentralised clinical trials.
Here, Ilesol Pharmaceuticals discuss how they became the first European cannabinoid company to unlock this sector of the market.
Here, CBDepot discuss how they worked with the European Commission to achieve a “valid” Novel Food Application.
Jay Sibbitts, Shu Jia, Obdulia Covarrubias-Zambrano, Stefan H. Bossmann and Christopher T Culbertson from Kansas State University’s Department of Chemistry walk us through what we need to know about microfluidic devices for detecting pain.
Health Canada led the world in large-scale cannabis legalisation and is now creating regulation for edible cannabis products: What is next?
Here, we discuss how unregulated industry patient advocates are integral to strengthening the credibility of growing CBD brands.